Cell Surface Markers Market | Coherent Market Insights - PowerPoint PPT Presentation

View by Category
About This Presentation

Cell Surface Markers Market | Coherent Market Insights


Read here the latest updates on the Cell Surface Markers Market published by CMI team. – PowerPoint PPT presentation

Number of Views:21


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Cell Surface Markers Market | Coherent Market Insights

Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • Covid-19 Impact Tracker

  • Cell Surface Markers Market, By Product Type
    (Flow Cytometers, Hematology Analyzers, Reagents
    and Kits), By Application (Disease Diagnosis and
    identification, Research/Drug Discovery), and By
    Region (North America, Latin America, Europe,
    Asia Pacific, Middle East Africa) - Size,
    Share, Outlook, and Opportunity Analysis, 2020 -

  • The global cell surface markers market is
    estimated to account for US 24,961.0 Mn in terms
    of value in 2020 and is expected to reach US
    44,373.4 Mn by the end of 2027.
  • Global Cell Surface Markers Market Drivers
  • Growing automation in laboratories is expected to
    propel growth of the global cell surface markers
    market over the forecast period. Huge inflow of
    data pertaining to patient details, clinical
    information, type of test, and the instruments
    required demands streamlining of such processes.
    Rapid detection of critical medical conditions
    can be easily facilitated through the use of
    sophisticated laboratory equipment such as flow
    cytometers. Availability of high-end and faster
    cell sorting and analysis solutions in flow
    cytometers for research and clinical development
    facilitates easier use of point of care diagnosis
    through automation of sample processing and
    enabling high throughput screening.

  • Global Cell Surface Markers Market Share (), by
    Value, by Region, 2019

  • Global Cell Surface Markers Market Restraints
  • Reluctance in high investment in sophisticated
    models is expected to hinder growth of the
    market. Due to the complexity and high cost of
    instruments and the simultaneous uncertainty
    surrounding the regulation and reimbursement for
    cell marker diagnostic tests, many clinical
    laboratories are reluctant to invest in
    sophisticated cell marker analysis instruments.
    Need for such devices also depends on the size
    and nature of the diagnostic facility. Economic
    concerns regarding operational sustainability in
    medium and small sized clinical laboratories and
    hospitals results in the outsourcing of such
    tasks to larger clinical laboratories.
  • Moreover, small pharmaceutical companies also are
    becoming increasingly reluctant to invest in
    highly sophisticated flow cytometers and
    hematology analyzers, owing to the unclear
    cost-benefit relationship. As drug development
    itself is a costly affair, smaller pharmaceutical
    firms cannot afford to get involved in the
    purchase of expensive equipment and consumables.
    This is turn is also expected to limit market

Cell Surface Markers Market Report Coverage

  • Global Cell Surface Markers Market Opportunities
  • Cell surface markers play a vital role in drug
    discovery and personalized medicine. Thus
    investment in drug discovery and personalized
    medicine is expected to offer lucrative growth
    opportunities for players in the global cell
    surface markers market. For instance, in May
    2020, The Israel Precision Medicine Partnership
    has chosen 16 multidisciplinary projects that
    will together receive around US 17 million in
    funding for developing nanoparticles to treat
    cancer, identifying genes to fight inherited
    retinal diseases, and studying the genetic
    aspects of autism.
  • Moreover, RD in adoptive immunotherapies is also
    expected to aid in growth of the market. For
    instance, in March 2020, researchers from
    Institute for Tumor Biology and Experimental
    Therapy, Germany, reported examining expression
    of various NK-cell-associated cell surface
    markers in the different feeder cell-expanded NK
    cell pools in the research Directed
    Differentiation of Mobilized Hematopoietic Stem
    and Progenitor Cells into Functional NK Cells
    with Enhanced Antitumor Activity.
  • The global cell surface markers market was valued
    at US 23,037.4 Mn in 2019 and is forecast to
    reach a value of US 44,373.4 Mn by 2027 at a
    CAGR of 8.6 between 2020 and 2027.

Global Cell Surface Markers Market Value (US
Mn), and Y-o-Y Growth (), 2019-2027

  • Market Trends/Key Takeaways
  • Cell surface marker analysis through the use of
    technologies like flow cytometry is expected to
    allow simplification of disease analysis, sample
    preparation and disease diagnosis. Currently a
    wide range of assay technologies for cell surface
    marker research are available in the market to
    enable the analysis of gene expression and
    regulation, genotyping, signal transduction and
    epigenetic modification. Some of the most common
    solutions available for cell surface marker
    analysis are PCR array, siRNA, miRNA, pathway
    reporter, mutation analysis, DNA methylation,
    protein expression and chromatin IP products.
  • Complexity of high-end flow cytometers and high
    cost of reagents, controls and analysis systems
    result in lowering the adoption of sophisticated
    cell marker analysis solutions, particularly in
    emerging economies. Increased market
    consolidation, simplification of analysis
    products, cost containment of such products and
    introduction of cheaper products is required to
    sustain in the cell surface markers market in
    such regions.

  • Global Cell Surface Markers Market Competitive
  • Major players operating in the global cell
    surface markers market include, Abbott
    Laboratories, Inc., Beckman Coulter, Inc., BD
    Biosciences, Bio-Rad Laboratories, Inc., Grifols
    SA, Immucor, Inc., Janssen Diagnostics, Inc.,
    Nihon Kohden Corporation, F. Hoffmann-La Roche
    Ltd., Siemens Healthcare, Sysmex Corporation, and
    Thermo Fisher Scientific, Inc.
  • Global Cell Surface Markers Market Key
  • Major players in the market are focused on
    product approval and launch to expand their
    product portfolio. For instance, in May 2020,
    Beckman Coulter launched its DxH 690T hematology
    analyzer featuring mid-volume laboratories
    advanced features such as the Early Sepsis
    Indicator in the U.S.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//www.coherentmarketinsights.com/

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com